Drug intelligence / Profile preview

cymbopogon proximus extract

Development stage
Preclinical
Administration
Oral
01

Overview

Cymbopogon proximus extract is a preparation derived from the aerial parts of the wild grass Cymbopogon proximus, used in Egyptian and Sudanese folk medicine. The extract comprises essential oils and various metabolites, notably sesquiterpenes (e.g., proximadiol, β-eudesmol, α-eudesmol) and flavonoids (e.g., apigenin, luteolin derivatives). It exerts multiple pharmacological activities, including antispasmodic (smooth muscle relaxation without abolishing propulsive activity), diuretic, antihypertensive, antioxidant, hypoglycemic, hypolipidemic, sedative, anxiolytic, anticonvulsant, and antimicrobial effects. Mechanistic studies and phytochemical profiling suggest activity is mediated via smooth muscle relaxation (potentially through calcium channel-blocking and antimuscarinic effects), modulation of pancreatic TNF-α, enhancement of GLUT4-mediated glucose uptake, and antioxidant defenses. Traditionally, the extract has been employed for nephrolithiasis, renal colic, urinary tract conditions, hypertension, nervous and gastrointestinal disorders, and as a general sedative[1][2][3][4][5][6][9].

Brand names
Proximol
Other names
HalfabarMaharaibAlmahrebEgyptian lemongrassCymbopogon proximus Hochst. ex A.Rich.
02

Targets

mAChR (Muscarinic acetylcholine receptors)CaV (Voltage-gated calcium channel protein complex)TNFA (Tumor necrosis factor alpha (soluble))

Beyond the preview

Go deeper on cymbopogon proximus extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on cymbopogon proximus extract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call